UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000056357 |
|---|---|
| Receipt number | R000064392 |
| Scientific Title | G-CSF Treatment for Agranulocytosis Induced by Antithyroid Drugs |
| Date of disclosure of the study information | 2024/12/07 |
| Last modified on | 2025/10/18 19:03:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2024/12/04 15:49:14 | ||
| 2 | Update | 2024/12/27 09:16:21 | Recruitment status |
|
| 3 | Update | 2024/12/27 12:46:12 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 4 | Update | 2025/05/14 09:51:04 | Condition Condition |
|
| 5 | Update | 2025/05/14 10:28:15 | Blinding No. of arms Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Interventions/Control_3 Interventions/Control_3 Key inclusion criteria Key inclusion criteria Target sample size |
|
| 6 | Update | 2025/05/14 10:34:39 | Interventions/Control_3 Interventions/Control_3 |
|
| 7 | Update | 2025/05/18 22:43:38 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 8 | Update | 2025/05/18 22:44:48 | Target sample size |
|
| 9 | Update | 2025/05/30 14:51:43 | Target sample size |
|
| 10 | Update | 2025/06/01 17:17:16 | Target sample size |
|
| 11 | Update | 2025/06/12 22:04:52 | Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes |
|
| 12 | Update | 2025/08/11 15:32:41 | Condition Condition Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 13 | Update | 2025/08/17 12:55:31 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 14 | Update | 2025/08/17 12:56:49 | Key inclusion criteria Key inclusion criteria |
|
| 15 | Update | 2025/10/18 19:03:22 | Last follow-up date |
|
| 16 | Update | 2025/10/18 19:03:45 | Target sample size |
